VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 627 filers reported holding VANECK VECTORS ETF TR in Q2 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $9,220,071 | +4.0% | 271,738 | -3.1% | 0.00% | 0.0% |
Q1 2024 | $8,868,705 | +2.8% | 280,478 | +0.9% | 0.00% | 0.0% |
Q4 2023 | $8,623,287 | +18088.4% | 278,081 | +15682.1% | 0.00% | – |
Q3 2023 | $47,411 | +10.2% | 1,762 | +23.3% | 0.00% | – |
Q2 2023 | $43,021 | -100.0% | 1,429 | -100.0% | 0.00% | -100.0% |
Q1 2023 | $359,759,994 | +770346.5% | 11,120,866 | +682580.5% | 0.02% | – |
Q4 2022 | $46,695 | -27.0% | 1,629 | -38.3% | 0.00% | – |
Q3 2022 | $64,000 | -12.3% | 2,640 | -1.3% | 0.00% | – |
Q2 2022 | $73,000 | -95.1% | 2,676 | -93.1% | 0.00% | – |
Q1 2022 | $1,489,000 | +18.8% | 38,846 | -0.8% | 0.00% | – |
Q4 2021 | $1,253,000 | -18.2% | 39,153 | -24.8% | 0.00% | – |
Q3 2021 | $1,532,000 | -98.9% | 52,034 | -98.7% | 0.00% | -100.0% |
Q2 2021 | $136,105,000 | +106.5% | 4,005,440 | +97.5% | 0.01% | +83.3% |
Q1 2021 | $65,906,000 | -44.3% | 2,027,871 | -38.3% | 0.01% | -45.5% |
Q4 2020 | $118,308,000 | -46.2% | 3,284,534 | -41.5% | 0.01% | -50.0% |
Q3 2020 | $219,740,000 | -8.0% | 5,611,352 | -13.8% | 0.02% | -15.4% |
Q2 2020 | $238,891,000 | +582561.0% | 6,512,852 | +365379.9% | 0.03% | – |
Q1 2020 | $41,000 | -70.9% | 1,782 | -63.0% | 0.00% | – |
Q4 2019 | $141,000 | +67.9% | 4,818 | +52.7% | 0.00% | – |
Q3 2019 | $84,000 | +23.5% | 3,155 | +18.7% | 0.00% | – |
Q2 2019 | $68,000 | +240.0% | 2,659 | +204.2% | 0.00% | – |
Q1 2019 | $20,000 | +17.6% | 874 | +8.0% | 0.00% | – |
Q4 2018 | $17,000 | – | 809 | +26866.7% | 0.00% | – |
Q3 2018 | $0 | -100.0% | 3 | -100.0% | 0.00% | – |
Q3 2017 | $2,595,000 | -98.6% | 113,010 | -98.7% | 0.00% | -100.0% |
Q2 2017 | $189,174,000 | -10.0% | 8,567,680 | -7.1% | 0.02% | -11.1% |
Q1 2017 | $210,290,000 | +14.5% | 9,219,202 | +5.0% | 0.03% | +8.0% |
Q4 2016 | $183,641,000 | +14.5% | 8,778,272 | +44.6% | 0.02% | +19.0% |
Q3 2016 | $160,421,000 | -12.9% | 6,069,663 | -8.7% | 0.02% | -16.0% |
Q2 2016 | $184,098,000 | – | 6,646,112 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |